US$ 27.32
dual agonist glp 1 glucagon Design of novel Xenopus GLP-1-based glucagon-like peptide (GLP-1)/ receptor agonists The mechanisms of dual incretin
Description
Strategic Implications for Stakeholders For Biopharma and Biotech Strategic decision-making is more critical than ever

Although Glp1r mRNA transcripts are detected in whole heart extracts such methods do not distinguish between vascular smooth muscle cells or atrial cardiomyocytes, there were technical difficulties in isolating pure cardiomyocyte populations from the ventricle without contamination of atrial cardiomyocytes isolated from neonatal mouse [36]

[DOI] [PubMed] [Google Scholar] 22

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles $119.00 per year only $9.92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
